Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Total Liabilities (2018 - 2025)

Outset Medical (OM) has disclosed Total Liabilities for 7 consecutive years, with $137.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 44.76% to $137.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $137.5 million, a 44.76% decrease, with the full-year FY2025 number at $137.5 million, down 44.76% from a year prior.
  • Total Liabilities was $137.5 million for Q4 2025 at Outset Medical, up from $134.9 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $253.0 million in Q1 2024 to a low of $73.2 million in Q1 2021.
  • A 5-year average of $145.4 million and a median of $136.2 million in 2025 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: crashed 77.95% in 2021, then soared 79.51% in 2023.
  • Outset Medical's Total Liabilities stood at $89.4 million in 2021, then skyrocketed by 72.43% to $154.1 million in 2022, then rose by 23.87% to $190.9 million in 2023, then skyrocketed by 30.41% to $249.0 million in 2024, then crashed by 44.76% to $137.5 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Total Liabilities are $137.5 million (Q4 2025), $134.9 million (Q3 2025), and $134.0 million (Q2 2025).